MedPath

Sumatriptan Succinate

Sumatriptan succinate

Approved
Approval ID

68daf82a-334e-43ca-b4bb-5c66a82f52c8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 1, 2020

Manufacturers
FDA

Proficient Rx LP

DUNS: 079196022

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sumatriptan Succinate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63187-049
Application NumberANDA076847
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sumatriptan Succinate
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 1, 2020
FDA Product Classification

INGREDIENTS (10)

sumatriptan succinateActive
Quantity: 50 mg in 1 1
Code: J8BDZ68989
Classification: ACTIM
croscarmellose sodiumInactive
Code: M28OL1HH48
Classification: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
talcInactive
Code: 7SEV7J4R1U
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT
mannitolInactive
Code: 3OWL53L36A
Classification: IACT
titanium dioxideInactive
Code: 15FIX9V2JP
Classification: IACT
triacetinInactive
Code: XHX3C3X673
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sumatriptan Succinate - FDA Drug Approval Details